"It's not a one operation fits all": A qualitative study exploring fee setting and participation in price transparency initiatives amongst medical specialists in the Australian private healthcare sector.

Australia Behavior change Out-of-pocket costs Price transparency Private health insurance Specialist fees

Journal

Social science & medicine (1982)
ISSN: 1873-5347
Titre abrégé: Soc Sci Med
Pays: England
ID NLM: 8303205

Informations de publication

Date de publication:
Dec 2023
Historique:
received: 08 04 2023
revised: 31 07 2023
accepted: 23 10 2023
medline: 4 12 2023
pubmed: 22 11 2023
entrez: 21 11 2023
Statut: ppublish

Résumé

The Australian government, through Medicare, defines the type of medical specialist services it covers and subsidizes, but it does not regulate prices. Specialists in private practice can charge more than the fee listed by Medicare depending on what they feel 'the market will bear'. This can sometimes result in high and unexpected out-of-pocket (OOP) payments for patients. To reduce pricing uncertainty and 'bill shock' faced by consumers, the government introduced a price transparency website in December 2019. It is not clear how effective such a website will be and whether specialists and patients will use it. The aim of this qualitative study was to explore factors influencing how specialists set their fees, and their views on and participation in price transparency initiatives. We conducted 27 semi-structured interviews with surgical specialists. We analysed the data using thematic analysis and responses were mapped to the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behavior model. We identified several patient, specialist and system-level factors influencing fee setting. Patient-level factors included patient characteristics, circumstance, complexity, and assumptions regarding perceived value of care. Specialist-level factors included perceived experience and skills, ethical considerations, and gendered-behavior. System-level factors included the Australian Medical Association recommended price list, practice costs, and supply and demand factors including perceived competition and practice location. Specialists were opposed to price transparency websites and lacked motivation to participate because of the complexity of fee setting, concerns over unintended consequences, and feelings of frustration they were being singled out. If price transparency websites are to be pursued, specialists' lack of motivation to participate needs to be addressed.

Identifiants

pubmed: 37988804
pii: S0277-9536(23)00710-4
doi: 10.1016/j.socscimed.2023.116353
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

116353

Informations de copyright

Copyright © 2023 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Hana Sabanovic (H)

Centre for Health Policy, The University of Melbourne, Parkville, VIC, Australia. Electronic address: hana.sabanovic@unimelb.edu.au.

Camille La Brooy (C)

Centre for Health Policy, The University of Melbourne, Parkville, VIC, Australia. Electronic address: clabrooy@unimelb.edu.au.

Susan J Méndez (SJ)

Melbourne Institute: Applied Economic & Social Research, The University of Melbourne, Parkville, VIC, Australia. Electronic address: susan.mendez@unimelb.edu.au.

Jongsay Yong (J)

Melbourne Institute: Applied Economic & Social Research, The University of Melbourne, Parkville, VIC, Australia. Electronic address: jongsay@unimelb.edu.au.

Anthony Scott (A)

Melbourne Institute: Applied Economic & Social Research, The University of Melbourne, Parkville, VIC, Australia. Electronic address: a.scott@unimelb.edu.au.

Adam G Elshaug (AG)

Centre for Health Policy, The University of Melbourne, Parkville, VIC, Australia. Electronic address: adam.elshaug@unimelb.edu.au.

Khic-Houy Prang (KH)

Centre for Health Policy, The University of Melbourne, Parkville, VIC, Australia. Electronic address: khic-houy.prang@unimelb.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH